Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial
Clinical trial NCT05382390 · UNKNOWN
Trial details
- NCT number
- NCT05382390
- Sponsor
- Huihan Wang
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2024-01-21
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.